MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directoryMedication intelligence platform that combines AI, clinical expertise, and population data to identify medication-related problems and guide interventions.
Plans and value-based organizations that need scalable medication optimization across quality, adherence, high-risk patient, and prescriber outreach programs.
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Arine as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as medication management and population-health decision support unless configured for direct clinical decisions; align use with pharmacist, care-team, quality, and plan obligations. |
|---|---|
| Privacy | Review claims, pharmacy, clinical, SDoH, outreach, language, and member-contact data flows plus BAAs, consent posture, subcontractors, retention, and audit controls. |
| Evidence | Validate program-level outcomes, recommendation acceptance, adherence and hospitalization claims, subgroup performance, and causal assumptions against local or plan data. |
| Workflow | Best used with pharmacist and care-team review, defined outreach scripts, prescriber engagement rules, quality-measure ownership, and continuous monitoring. |
Arine describes an AI-powered medication intelligence platform for health plans and at-risk providers, using clinical, behavioral, social, pharmacy, and medical data to identify medication-related problems and support tailored recommendations, MTM, prescriber outreach, and high-risk patient programs.
Not for: Point-of-care prescribing automation, emergency decisions, or member interventions without pharmacist, care-team, privacy, and quality-program governance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.